electroCore Review Highlights Cervical Vagus Nerve Stimulation as Clinically Validated Approach
Event summary
- electroCore published a peer-reviewed review article in Frontiers in Neuroscience on July 16, 2026.
- The review compares transcutaneous auricular vagus nerve stimulation (taVNS) and cervical vagus nerve stimulation (tcVNS).
- Peter S. Staats, MD, MBA, Chief Medical Officer of electroCore, co-authored the article with Justyna Blake, Senior Director of Medical Affairs.
- The review highlights tcVNS as a clinically validated approach within bioelectronic medicine.
The big picture
The publication of this review underscores the strategic importance of non-invasive vagus nerve stimulation in the bioelectronic medicine field. As interest in these technologies accelerates, electroCore positions itself as a leader by providing an evidence-based framework for evaluating different approaches to vagus nerve stimulation. The review also highlights opportunities for future research and innovation, which could further solidify electroCore's role in this rapidly growing industry.
What we're watching
- Clinical Validation
- How the growing body of research supporting tcVNS will impact electroCore's market position and adoption rates.
- Technological Advancements
- The pace at which future investigations will optimize vagus nerve stimulation technologies for diverse clinical applications.
- Market Expansion
- Whether electroCore can leverage this review to expand its product offerings and enter new therapeutic areas.
Related topics